From Garage to Global Stage
Our story began in Silicon Valley when a cardiovascular surgeon and a team of medical technology veterans created what is now known as the ARTO System - a proprietary, implantable device to treat Functional Mitral Regurgitation (FMR).
We designed, built and tested the ARTO System from the ground up, starting in our garage. Through our determination and perseverance, our team has brought the ARTO System into clinical trials worldwide, bringing MVRx closer to providing innovative mitral valve repair therapy to many patients.
"We believe the ARTO System can revolutionize the treatment of heart failure patients suffering from mitral regurgitation."
- Robert Chang, President & Co-Founder